Fenofibrate
Grofibrat 200 belongs to a group of medicines known as fibrates. These medicines are used to lower the level of fats (lipids) in the blood. Examples of such fats are triglycerides.
Grofibrat 200 is used in combination with a low-fat diet and other non-drug treatments, such as physical exercise and weight loss, to lower the level of fats in the blood.
In some cases, Grofibrat 200 may be used in addition to other medicines (statins, such as simvastatin, atorvastatin, pravastatin, rosuvastatin, or fluvastatin), if the level of fats in the blood cannot be controlled with statins alone.
Do not take Grofibrat 200 if any of the above applies to you. In case of doubt, consult a doctor or pharmacist before taking Grofibrat 200.
Before starting treatment with Grofibrat 200, discuss it with your doctor or pharmacist if:
Stop taking the medicine immediately and consult a doctor if you experience unexpected muscle cramps or pain, muscle tenderness, or muscle weakness while taking Grofibrat 200.
The risk of muscle breakdown may be higher in some patients. Inform your doctor if:
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Particularly, inform your doctor about taking medicines such as:
If any of the above warnings apply to you (or in case of doubt), consult a doctor or pharmacist before starting treatment with Grofibrat 200.
It is important to take the medicine with a meal, as its absorption will be reduced if taken on an empty stomach.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult a doctor or pharmacist before taking this medicine.
Grofibrat 200 has no effect on driving or using machines.
If you have been diagnosed with an intolerance to some sugars, consult your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, consult your doctor or pharmacist.
Your doctor will determine the appropriate dose of the medicine based on your condition, current treatment, and personal risk.
The recommended daily dose is 1 capsule of 200 mg once a day.
In patients with kidney failure, the doctor may reduce the dose. If you have kidney problems, consult your doctor or pharmacist. In patients with severe kidney failure (creatinine clearance <20 ml min), the medicine is contraindicated.< p>
In elderly patients without kidney failure, the recommended dose is the same as for adults.
In patients with liver failure, Grofibrat 200 is not recommended due to the lack of clinical data for this group.
Grofibrat 200 is not recommended for children and adolescents under 18 years of age.
If you have taken more than the recommended dose, or if someone else has taken your medicine, contact a doctor or the emergency department of your nearest hospital immediately.
In case of doubt, consult your doctor.
Do not stop treatment without consulting your doctor, unless the medicine is causing you harm. High cholesterol must be treated for a long time.
Remember that, in addition to taking Grofibrat 200, it is also important to:
Like all medicines, Grofibrat 200 can cause side effects, although not everybody gets them.
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Frequency not known:frequency cannot be estimated from the available data
If you experience any of the above side effects, stop taking Grofibrat 200 and contact your doctor immediately.
If you experience any of the following side effects, contact your doctor or pharmacist:
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
| |
| |
| |
| |
| |
| |
laboratory tests, | |
| |
are associated with a higher risk of coronary heart disease, stroke, and peripheral vascular disease, although a causal relationship has not been established yet). |
| |
| |
| |
| |
| |
laboratory tests. |
Rare: may affect up to 1 in 1,000 people | |
| |
| |
increased sensitivity of the skin to sunlight, sunlamps, and sunbeds, | |
| |
laboratory tests. |
Frequency not known:frequency cannot be estimated from the available data
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist or nurse.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is micronized fenofibrate.
Other ingredients are: lactose monohydrate, maize starch, microcrystalline cellulose, crospovidone, magnesium stearate, sodium lauryl sulfate, iron oxide red, iron oxide yellow, titanium dioxide, gelatin.
Grofibrat 200 is produced in the form of light orange capsules.
The pack contains 30 capsules.
GEDEON RICHTER POLSKA Sp. z o. o.
Poniatowskiego 5 Street
05-825 Grodzisk Mazowiecki
Poland
phone: +48 (22) 755 50 81
To obtain more detailed information, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
Medical Department
Poniatowskiego 5 Street
05-825 Grodzisk Mazowiecki
Phone: +48 (22) 755 96 48
lekalert@grodzisk.rgnet.org
((marketing authorization holder's logo))
((pharmacode))
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.